NRXP NRX Pharmaceuticals, Inc. - Common Stock
$2.98
Price · May 20, 2026
Fundamentals as of May 15, 2026
52W Range
$2–$4
61% of range
Analyst Rating
BUY
10 analysts
Price Target
$40
+1256% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
NRXP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.98
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$2 – $4
NRXP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
NRXP
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
NRXP
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
NRXP
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
NRXP
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
NRXP
Peer Median
NRXP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
10 analysts
- Strong Buy 3 30.0%
- Buy 6 60.0%
- Hold 1 10.0%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
5 analysts · 2026-05-17
Median
$45.00
Mean
$40.40
← Below all targets
$2.98
Low
$25.00
High
$49.00
Median target
$45.00
+1410.1%
Mean target
$40.40
+1255.7%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-0.20%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.04 | $0.29 | -0.33% |
| Dec. 31, 2025 | $-0.01 | $-0.00 | -0.01% |
| Sept. 30, 2025 | $-0.50 | $-0.09 | -0.41% |
| June 30, 2025 | $-0.31 | $-0.21 | -0.10% |
| March 31, 2025 | $-0.21 | $-0.31 | 0.10% |
| Dec. 31, 2024 | $-0.77 | $-0.32 | -0.45% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NRXP | — | — | — | — | — | — |
| RANI | — | -3.0 | 58.9% | -1817.1% | -169.6% | — |
| CGTX | $120M | -4.2 | — | — | -113.7% | — |
| VRCA | $143M | -4.9 | 370.2% | -50.3% | -492.8% | — |
| AARD | $286M | -4.5 | — | — | -47.3% | — |
| LONA | $71M | -0.3 | — | — | -353.4% | — |
| TELO | $46M | -4.0 | — | — | -325.7% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 13
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Revenue | $1M | $0 | |
| Cost of Revenue | $631.0K | $0 | |
| R&D Expense | $1M | $804.0K | |
| SG&A Expense | $4M | $3M | |
| Operating Expenses | $6M | $4M | |
| Operating Income | $-5M | $-4M | |
| Interest Income | $5.0K | $4.0K | |
| Other Non-op | $3M | $-2M | |
| Income Tax | $0 | $0 | |
| Net Income | $-1M | $-6M | |
| EPS (Basic) | $-0.04 | $-0.34 | |
| Shares (Basic) | 32,325,323 | 16,410,062 | |
| EBITDA | $-5M | · |
Balance Sheet 20
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Cash & Equivalents | $7M | · | |
| Receivables | $181.0K | · | |
| Prepaid Expense | $467.0K | · | |
| Current Assets | $7M | · | |
| PP&E (Net) | $259.0K | · | |
| PP&E (Gross) | $306.0K | · | |
| Accum. Depreciation | $47.0K | · | |
| Goodwill | $2M | · | |
| Intangibles | $879.0K | · | |
| Other Non-current Assets | $276.0K | · | |
| Total Assets | $12M | · | |
| Accounts Payable | $4M | · | |
| Current Liabilities | $25M | · | |
| Total Liabilities | $26M | · | |
| Common Stock | $33.0K | · | |
| Paid-in Capital | $294M | · | |
| Retained Earnings | $-308M | · | |
| Stockholders' Equity | $-14M | · | |
| Liabilities + Equity | $12M | · | |
| Shares Outstanding | 33,471,315 | · |
Cash Flow 10
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| D&A | $63.0K | $1.0K | |
| Stock-based Comp | $151.0K | $12.0K | |
| Other Non-cash | $-3M | · | |
| Operating Cash Flow | $-4M | $-3M | |
| Investing Cash Flow | $-213.0K | $0 | |
| Stock Issued | $3M | $0 | |
| Net Stock Activity | $3M | · | |
| Financing Cash Flow | $3M | $8M | |
| Net Change in Cash | $-1M | $4M | |
| Taxes Paid | $0 | $0 |
Profitability 5
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Operating Margin | -444.0% | · | |
| Net Margin | -133.9% | · | |
| EBITDA Margin | -438.1% | · | |
| ROA | -14.7% | · | |
| ROE | 7.3% | · |
Liquidity & Solvency 2
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Current Ratio | 0.3 | · | |
| Quick Ratio | 0.3 | · |
Efficiency 2
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Asset Turnover | 0.1 | · | |
| Receivables Turnover | 11.8 | · |
Valuation (TTM) 6
| Metric | Trend | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Net Income TTM | $-30M | · | |
| Market Cap | $71M | · | |
| P/E | -0.8 | · | |
| P/B | -5.2 | · | |
| P / Cash Flow | -16.6 | · | |
| Earnings Yield | -121.6% | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.